FDA Approves Daprodustat, First Oral Anemia Treatment

The US Food and Drug Administration has approved daprodustat as oral treatment for anemia in patients with chronic kidney disease and on dialysis, but not for patients who are not on dialysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/987789?src=rss